Edition:
United States

E-Therapeutics PLC (ETXP.L)

ETXP.L on London Stock Exchange

8.05GBp
9:35am EDT
Change (% chg)

-0.20 (-2.42%)
Prev Close
8.25
Open
8.25
Day's High
--
Day's Low
--
Volume
49,308
Avg. Vol
50,842
52-wk High
14.90
52-wk Low
7.00

ETXP.L

Chart for ETXP.L

About

e-Therapeutics plc is a United Kingdom-based drug discovery and development company. The Company's discovery platform is based on the network of pharmacology and chemical biology. The Company operates in the business segment of drug discovery and development. The Company applies its platform to the discovery of new drug... (more)
No analyst recommendations are available for ETXP.L.

Overall

Beta: 0.97
Market Cap(Mil.): £22.15
Shares Outstanding(Mil.): 268.43
Dividend: --
Yield (%): --

Financials

  ETXP.L Industry Sector
P/E (TTM): -- 58.41 30.30
EPS (TTM): -0.05 -- --
ROI: -59.11 0.45 13.24
ROE: -59.11 6.31 14.40

BRIEF-E-Therapeutics says director Sean Nicolson to leave co

* Sean Nicolson, executive director & Company Secretary will be leaving in order to focus on other business commitments Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

Feb 16 2017

More From Around the Web

Earnings vs. Estimates